| Date Filed | Type | Description |
| 08/16/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 68 restricted stock units
@ $0 |
|
| 07/17/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 69 restricted stock units
@ $0 |
|
| 06/16/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 5,531 restricted stock units
@ $0
Granted 8,803 options to buy
@ $38.005, valued at
$334.6k
Granted 5,592 restricted stock units
@ $0
Exercised 68 restricted stock units
@ $0 |
|
| 05/16/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 68 restricted stock units
@ $0 |
|
| 04/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 68 restricted stock units
@ $0
Exercised 68 restricted stock units
@ $0 |
|
| 03/10/2023 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Disposed/sold 3,673 shares
@ $0
Disposed/sold 45,000 options to buy
@ $26.17, valued at
$1.2M
Disposed/sold 58,608 options to buy
@ $7.65, valued at
$448.4k
Disposed/sold 21,603 options to buy
@ $21.47, valued at
$463.8k
Disposed/sold 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/18/2022 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Exercised 820 restricted stock units
@ $0 |
|
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/10/2021 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Guardant Health, Inc.|
Txns:
| Granted 3,283 restricted stock units
@ $0
Granted 5,613 options to buy
@ $110.43, valued at
$619.8k
|
|
| 11/09/2021 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 21,096 options to buy
@ $22.71, valued at
$479.1k
|
|
| 10/27/2021 |
3
| POTTER MYRTLE S (Director) has filed a Form 3 on Guardant Health, Inc. |
| 03/31/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 21,603 options to buy
@ $21.47, valued at
$463.8k
|
|
| 07/23/2020 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 01/14/2020 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 12/20/2019 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Immunovant, Inc.|
Txns:
| Granted 137,617 options to buy
@ $7.86, valued at
$1.1M
Granted 893 options to buy
@ $7.86, valued at
$7k
Granted 11,488 options to buy
@ $8.43, valued at
$96.8k
Granted 3,765 options to buy
@ $8.43, valued at
$31.7k
|
|
| 12/20/2019 |
3
| POTTER MYRTLE S (Director) has filed a Form 3 on Immunovant, Inc. |
| 08/27/2019 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 58,608 options to buy
@ $7.65, valued at
$448.4k
|
|
| 08/20/2019 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 22,000 options
@ $0 |
|
| 07/11/2019 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 25,000 options to buy
@ $8.78, valued at
$219.5k
|
|
| 06/10/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/17/2019 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 255,000 options to buy
@ $1.06, valued at
$270.3k
|
|
| 11/26/2018 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 50,000 options to buy
@ $8.01, valued at
$400.5k
|
|
| 10/22/2018 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Arbutus Biopharma Corp|
Txns:
| Granted 44,000 options to buy
@ $4.71, valued at
$207.2k
|
|
| 10/22/2018 |
3
| POTTER MYRTLE S (Director) has filed a Form 3 on Arbutus Biopharma Corp |
| 10/16/2018 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Axovant Sciences Ltd.|
Txns:
| Granted 150,000 options to buy
@ $2.37, valued at
$355.5k
|
|
| 10/05/2018 |
3
| POTTER MYRTLE S (Director) has filed a Form 3 on Axovant Sciences Ltd. |
| 09/26/2018 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/24/2018 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Myovant Sciences Ltd.|
Txns:
| Granted 45,000 options to buy
@ $26.17, valued at
$1.2M
|
|
|